Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

« Older Entries
Newer Entries »

VIDEO – Canadian Trucker Protests & Ukrainian Invasion Accelerate Demand For KWESST Non-Lethal & Soldier Decoy Technologies

Posted by AGORACOM-JC at 4:57 PM on Monday, March 7th, 2022
Kwe large new

KWESST Micro Systems (KWE:TSXV) offers high-tech, covert defense systems that we only get to see in Tom Cruise movies.

$KWE is a leader in “soldier systems” technologies that increase the capabilities of soldiers.  Let’s be clear right off the start, KWESST doesn’t sell weaponry.  Rather, it sells technologies that make a big difference to the safety and effectiveness of soldiers.

For example, the Company’s PhantomTM electronic decoy technology helps prevent soldiers being located and killed due to electronic signals their equipment creates – by creating multiple electronic decoys that enemies can not differentiate. 

CANADIAN TRUCKER PROTESTS

Events like the trucker protests have created a pronounced increase in demand by law enforcement agencies for non-lethal equipment. $KWE ARWEN anti-riot equipment was used at the trucker protest in Ottawa to help bring a safe conclusion to the incident. As a result $KWE is now processing numerous quote requests for replenishment and expansion of anti-riot equipment.

UKRAINE INVASION

The invasion of Ukraine by Russia has been a major catalyst for KWESST’s PhantomTM electronic decoy, including several pending requests and price quotations to fill Urgent Operational Requirements for NATO forces. This level and urgency of interest leads $KWE to believe that it is highly likely it could receive NATO country orders throughout its 2022 fiscal year and beyond.

ESTABLISHED TRACK RECORD OF SUCCESS

The company’s Leadership team experience spans decades and hundreds of millions of dollars in military and homeland security contracts. In addition it has partnered with globally recognized equipment manufacturers to integrate its systems into their solutions to create high value-add products for global customers, including SAMSUNG.

The company generated over $1.27M in revenue for the year ended Sept 30, 2021 but has already announced subsequent contracts surpassing this in the early months of this fiscal year.

The soldier systems market is projected to hit $14.5 Billion by 2023 and, up until  now, small cap investors have never had a company to participate in this lucrative (and SUPER COOL) market.

Watch this powerful interview with Executive Chairman David Luxton, who is a globally recognized entrepreneur in the defence and security industry. He was formerly an infantry officer and senior official with the Canadian and British governments before leading the global build-out of multiple defence and security companies. All together, companies under the leadership of David Luxton have generated over $1,000,000,000 (Billion) in sales.

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, KWESST Micro Systems Inc. | Comments Off on VIDEO – Canadian Trucker Protests & Ukrainian Invasion Accelerate Demand For KWESST Non-Lethal & Soldier Decoy Technologies

VIDEO: Azincourt Energy – Potential Uranium Discovery with Radioactivity Identified in 800m Alteration Zone

Posted by AGORACOM at 4:29 AM on Friday, March 4th, 2022

Azincourt Energy is developing critical alternative energy projects for uranium and lithium. It’s core projects are in the clean energy space focusing on uranium exploration projects in the Athabasca Basin, Saskatchewan.

More importantly they have 3rd party validation through institutional financing and ownership, to the tune of $8M+, and that is an important indicator to understanding a companies prospects. You need viable projects to attract funding, and in this case it is a large sum of money being devoted to a help Azincourt make a discovery.

They clearly have support.

Azincourt controls 70+% of the East Preston Uranium project located in the Athabasca basin in Saskatchewan that has numerous Uranium deposits, as well as mines operated by major mining companies. Saskatchewan has been a prolific jurisdiction for Uranium mining and production for 40+ years and contains 10 to 100 times the world average Uranium grades.
This makes finding an economic discovery feasible. That is part of the 3rd party validation that makes Azincourt compelling in the clean energy space.

Azincourt may have already justified the attention and investment received in advance of their current drill program as they just announced some very telling early indicators pointing toward a potential Uranium discovery.

On the K-Zone drilling has intersected extensive hydrothermal hematite alteration in all holes, indicating this alteration zone is at least 800 meters long. Drill hole EP0035 intersected an extensive zone of hydrothermal hematite more than 100 meters thick. Within this zone localized elevated radioactivity identified from both hand-held scintillometers and a downhole gamma probe was also encountered. Analysis of samples from this zone will be sent to the lab to evaluate the significance of the elevated radioactivity in this area. Additional drilling is underway to evaluate the significance of this alteration zone and to follow-up the elevated radioactivity identified.

On the G-Zone where eight holes have been completed and one hole is in progress, Extensive alteration and evidence of east-west cross-cutting structures have been intersected, along the southern portion of the zone. Additional drilling will be undertaken to evaluate the significance of this alteration and associated cross cutting structure.

2 separate zones, 2 Possible discoveries. Shareholders should pay very close attention to these early results. Being strategically located in the Athabasca Basin provides a leverage to discovery few early entrants to the space can demonstrate.

Why is Azincourt exploring in These areas? Quite simply the world needs clean energy.

The Uranium Market is demonstrating limited supply and growing demand and this provides a growth platform for explorco’s to capitalize on the need for uranium as Nuclear power is one of the safest forms of electricity generation. Nuclear power capacity worldwide is increasing steadily, with about 50 reactors under construction.

Take a seat ans have a listen to this great interview with Alex Klenman, President & CEO of Azincourt Energy (TSX.V: AAZ / OTC: AZURF) as he takes us through the steps why Azincourt may be the next Smallcap discovery in the Saskatchewan’s prolific Athabasca Basin.

Tags: , , , , ,
Posted in All Recent Posts, Azincourt Energy, Beyond The Press Release | Comments Off on VIDEO: Azincourt Energy – Potential Uranium Discovery with Radioactivity Identified in 800m Alteration Zone

AGORACOM Hits 14 Million Twitter Impressions, 3.6 Million YouTube Minutes In 2021. Shatters Engagement Metrics

Posted by AGORACOM-JC at 2:54 PM on Friday, February 25th, 2022
  • AGORACOM Twitter Engagement Metrics Beat Benchmarks By 230%*
  • AGORACOM Cashless Marketing Program Is 100% Compliant With TSXV, CSE and NEO

Last week we were proud to announce another AGORACOM major milestone when we surpassed 710 Million page views (81% AGORACOM / 19% Twitter) from 8.8 Million investors that visited 63.3 Million times over the last 13 years.

These milestones are significant because they continue to demonstrate that AGORACOM is the primary home for serious small cap investors that want to discover their next great small-cap investment.

Today we are proud to announce 2 more major milestones for the 2021 year:

  • 14 Million Impressions On Twitter
  • 3.6 Million Minutes On YouTube

TWITTER SUCCESS – 230% HIGHER ENGAGEMENT SMASHES BENCHMARKS

A picture is worth 1,000 words so our analytics snapshot says it all but we thought you’d like a little additional context to go with it:

MAKE SURE YOU FOLLOW US AND SHARE THE GREAT CONTENT WE CREATE FOR YOU!

If you haven’t seen the incredible year-round content we create for you, please make sure to ask your Account Executive to see it.  Then make sure your social media team is following us so that you can use and share our great content any way you like!

SMALL CAP INVESTORS LOVE AGORACOM VIDEO CONTENT

If a picture is worth 1,000 words, a great video is worth thousands of happy shareholders!

AGORACOM videos receive the highest engagement rates and shareholder testimonials in the industry because we take the time to produce both great content and high production value that viewers truly appreciate.  Click on the image below to see some of our recent great testimonials … or use this link!

MAKE SURE YOU FOLLOW US AND SHARE THE GREAT VIDEOS WE CREATE FOR YOU!

If you haven’t seen the incredible LONG & SHORT video content we create for you, please make sure to ask your Account Executive to see it.  Then make sure your social media team is following us so that you can use and share our great video content with your networks!

HOW DOES AGORACOM CREATE INDUSTRY-LEADING ENGAGEMENT?

The fight for investor attention is stronger than ever.  Within the small cap industry investors are inundated with mountains of information from email to social media. 

Moreover, the small cap industry is now facing stiff new competition for investor attention from the fast-rising Web3 world of Cryptocurrencies, NFTs and Blockchains.

It’s enough to make both investors and issuers dizzy.

AGORACOM overcomes this challenge and wins the battle for investor attention by going the extra mile to create great content. While most firms communicate via “lazy linking” AGORACOM Founder and former lawyer George Tsiolis relies on his communications training to make sure the account management team delivers the following winning variety of content:

FORM – Blogs, Posts, Tweets, Comments, Videos, Audio, Graphics and GIFs

LENGTH – Ultra Long, Long, Medium, Short and Micro

PLATFORMS – YouTube, Twitter, LinkedIn, Facebook, Instagram, Spotify, Search, TikToK (yeah but no dancing!) … and of course our very own AGORACOM.com

Click on the image below to watch a concise but powerful 75-second video to get a great glimpse of our industry-leading content machine … or just click on this link:

This unmatched variety in the form, length and distribution of our content removes all the noise for investors while providing clients with a complete digital marketing solution.       

ZERO $ … AGORACOM CASHLESS AND 100% COMPLIANT PROGRAM

As a small cap company, your cash is invaluable and shouldn’t be used for anything other than operations and growth. You’ll be happy to know The AGORACOM Cashless, Shares For Services Program is fully compliant with the TSX Venture, CSE and NEO Exchanges. As such, it is considered the friendliest comp structure in the entire industry and can be summarized as follows:

  • Shares are issued in 5 X $20,000 installments over the twelve month term.
  • Start Date
    • End Of Q1
    • End Of Q2
    • End Of Q3
    • End Of Q4
  • The number of shares issued is determined by the share price at each date.  As the issuer share price goes higher, the number of shares issued to AGORACOM decreases. 
  • Each issuance comes with customary 4-month hold periods. As such, AGORACOM is a shareholder for at least 16 months (Q4 + 4 Months)
  • Structure means AGORACOM becomes a long-term shareholder that is completely aligned with the Company
  • $0 Cash + the full firepower of AGORACOM

CONCLUSION

Massive audience

+ industry leading engagement

+ industry leading content

+ $0 cash, 100% compliant shares for services = Win – Win

Tags: , , , , , , , , ,
Posted in AGORACOM News And Events, AGORACOM Traffic, All Recent Posts | Comments Off on AGORACOM Hits 14 Million Twitter Impressions, 3.6 Million YouTube Minutes In 2021. Shatters Engagement Metrics

VIDEO – HealthSpace $25M Pipeline, Record Revenues and Multiple Million $$ Contracts With Government Efficiency Software

Posted by AGORACOM-JC at 5:31 PM on Wednesday, February 23rd, 2022
Healthspace logo 300 x 100

If there is one thing we know about governments (local, state, Federal) it is they have lots of responsibility AND are hugely inefficient.  Who hasn’t had a bad experience with government departments a few times in their life? Much of it stemming from antiquated software systems that often fail to keep track of critical information.  

HealthSpace “is empowering governments efficiency” which in turn has powered them to become an industry leading technology company providing both enterprise and mobile internet-based applications to over 500 state, local and federal government organizations across North America.

More Than Just Lip Service

RECORD REVENUE:

●       $1.038M Q ending Sept 30, 2021. Up 66% vs 2021

●       ~$2.8M in 9 months revenue. Up 85% vs same period in prior year

●       $US 25M+ Sales Pipeline

MAJOR CONTRACTS:

●       Riverside County California (New)                                     $1.3M

●       Sacramento County California                                           $1.55M

●       Fraser Health, BC                                                                       $1.01M

●       Larimer County, Colorado and Ogle County, Illinois  $517,400

●       Anaheim Fire and Rescue Department                             $193,990

●       $340,000 in New Contracts with Health Canada, Johnson County, MO, Shelby County, TN and KFLA in Ontario

FINANCINGS:

●       $5.2 Million financings recently closed

On today’s interview we’ll be discussing, US$1.3 Million Contract with Riverside County, California.  This contract will add an average of US$148,000 in Annual Recurring Revenue not including future revenue anticipated as part of HSPay. 

What did HealthSpace CEO, Silas Garrison have to say?

“I am pleased to announce our first contract of 2022.  Fittingly, it is in California ; a market that we have served well and continues to look to us during a period of technology transition for environmental health departments across the state.  We appreciate the trust agencies all around California are placing in HealthSpace, and we look forward to much growth in the state, as well as the rest of the county, as we progress through 2022.”

Sit back, relax and watch this powerful interview.

Tags: , , , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, HealthSpace Data Systems Ltd. | Comments Off on VIDEO – HealthSpace $25M Pipeline, Record Revenues and Multiple Million $$ Contracts With Government Efficiency Software

AGORACOM Surpasses 710 Million Page Views From 63.3 Million Visits And 8.8 Million Users. Shatters Industry Engagement Metrics

Posted by AGORACOM-JC at 8:28 AM on Friday, February 18th, 2022
*AGORACOM Engagement Metrics Beat Benchmarks By 364%
*AGORACOM Cashless Marketing Program Is 100% Compliant With TSXV, CSE and NEO 

We are very proud to announce AGORACOM achieved another major milestone for the period December 31, 2021, when we surpassed 710 Million page views (81% AGORACOM / 19% Twitter) from 8.8 Million investors that visited 63.3 Million times over the last 13 years. 

These milestones are significant because they continue to demonstrate that AGORACOM is the primary home for serious small cap investors that want to discover their next great small cap investment. We owe much of this success to the following 2 major factors: 

QUALITY OVER QUANTITY – Unlike small cap sites and major platforms that struggle with spam, profanity and overall nonsense, AGORACOM has implemented and strictly enforces it’s 6 Rules Of Use that create robust but civilized debate and discussion. 

FOCUS. NOTHING BUT SMALL CAP – Despite the fact we are all in the finance industry, we don’t talk about macro finance, large cap or general economic news.  Investors come to AGORACOM for just one thing – great small cap content .. and they don’t hesitate to show their love for us. 

AGORACOM ENGAGEMENT SHATTERS FINANCE BENCHMARKS BY 364% 

AGORACOM small cap investors don’t just flip through pages, they invest a significant amount of time reading, studying and researching our small cap stocks like yours. …. And they do it far more than everywhere else.  Here are the numbers: 

PAGES READ PER VISIT  > 364% HIGHER THAN INDUSTRY STANDARD 

In a recent survey of 357 finance sites, LittleData determined the average number of pages read per visit was 2.0. The average number of pages read on AGORACOM are 9.28, which is 364% higher than the benchmark.  

Moreover, when it came to the best 10% of all finance sites, AGORACOM has them beat hands down as well, with LittleData determining anything greater than 4.1 pages per visit represents the best 10% of all Finance sites. With AGORACOM registering 9.67 pages per visit for a 136% beat, it is fair to say AGORACOM is in elite status for engagement.  

TIME SPENT PER VISIT  > 161% HIGHER THAN INDUSTRY STANDARD 

The average visitor to AGORACOM stays on the site for an average of 8 mins 23 secs. To put this into perspective, The Contentsquare Digital Experience Benchmark Report determined an average visit to financial services sites of 3 mins 13 secs, placing AGORACOM engagement 161% higher. Here are some comparables against some of the world’s biggest finance sites: 

AGORACOM              8 mins 23 secs
Wall Street Journal     3 mins 18 secs
Marketwatch               5 mins 47 secs              
Motley Fool                 1 mins 50 secs
FOX Business             3 mins 39 secs
Investing.com             5 mins 53 secs 

HOW DOES AGORACOM CREATE INDUSTRY LEADING ENGAGEMENT? 

The fight for investor attention is stronger than ever.  Within the small cap industry investors are inundated with mountains of information from email to social media.   

Moreover, the small cap industry is now facing stiff new competition for investor attention from the fast rising Web3 world of Cryptocurrencies, NFTs and Blockchains.  

It’s enough to make both investors and issuers dizzy. 

AGORACOM overcomes this challenge and wins the battle for investor attention by going the extra mile to create great content. While most firms communicate via “lazy linking” AGORACOM Founder and former lawyer George Tsiolis relies on his communications training to make sure the account management team delivers the following winning variety of content: 

FORM – Blogs, Posts, Tweets, Comments, Videos, Audio, Graphics and GIFs  

LENGTH – Ultra Long, Long, Medium, Short and Micro 

PLATFORMS – YouTube, Twitter, LinkedIn, Facebook, Instagram, Spotify, Search, TikToK (yeah but no dancing!) … and of course our very own AGORACOM.com  

Watch this concise but powerful 60-second video to get a great glimpse of our industry leading content machine. This unmatched variety in the form, length and distribution of our content removes all the noise for investors while providing clients with a complete digital marketing solution.         

ZERO $ … AGORACOM CASHLESS AND 100% COMPLIANT PROGRAM 

As a small cap company, your cash is invaluable and shouldn’t be used for anything other than operations and growth. You’ll be happy to know The AGORACOM Cashless, Shares For Services Program is fully compliant with the TSX Venture, CSE and NEO Exchanges. As such, it is considered the friendliest comp structure in the entire industry and can be summarized as follows: 

Shares are issued in 5 X $20,000 installments over the twelve month term. 

-Start Date
-End Of Q1
-End Of Q2
-End Of Q3
-End Of Q4 

-The number of shares issued is determined by the share price at each date.  As the issuer share price goes higher, the number of shares issued to AGORACOM decreases.   

-Each issuance comes with customary 4-month hold periods. As such, AGORACOM is a shareholder for at least 16 months (Q4 + 4 Months) 

-Structure means AGORACOM becomes a long-term shareholder that is completely aligned with the Company 

-$0 Cash + the full firepower of AGORACOM 

CONCLUSION  

Massive audience 
+ industry leading engagement
+ industry leading content
+ $0 cash, 100% compliant shares for services  

= Win – Win 

Tags: , , , , , ,
Posted in AGORACOM Traffic, All Recent Posts | Comments Off on AGORACOM Surpasses 710 Million Page Views From 63.3 Million Visits And 8.8 Million Users. Shatters Industry Engagement Metrics

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 10:53 AM on Saturday, February 5th, 2022

The Roundup

A weekly summary of Novamind news and media

Novamind Hosts Clinical Trial to Advance Ketamine Therapy for End-of-Life Patients

We are pleased to announce we have been selected by the Ketamine Research Foundation (KRF) to host a phase II clinical trial investigating ketamine-assisted psychotherapy (KAP) for adults with life-threatening illness (Conscious Dying/Conscious Living Trial).

“This study is an important addition to the clinical care and research opportunities for patients within the Psychedelic Palliative Care program that we are building at Novamind,” said Dr. Paul Thielking, Chief Scientific Officer and Principal Investigator at Novamind’s Murray research site. “I’ve worked with this population for most of my career and, unfortunately, I’ve sometimes felt limited in what I can offer my patients to ease their emotional distress. The findings will contribute to the evidence for using KAP with patients who have a life-threatening illness and offer new insights into alternative treatments.”

Read the full release here.

February 3, 2022

View all press releases

February 1, 2022

Anger Issues

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore the many facets of anger. They discuss the following: how conditioning affects how we process emotions like anger, the corrective emotional experience afforded by MDMA-assisted psychotherapy and much more.

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com. 

Email us questions and feedback at [email protected].

February 4, 2022

The Present and Future of Novamind, a Conversation with Citi

CEO, Yaron Conforti and Chief Medical Officer, Dr. Reid Robison recently met up with Citi to share our mission with their global investor base. 

January 31, 2022

We’re Heading into Pivotal Years for Psychedelics – Here’s Why

Dr. Reid Robison took a moment to write about his thoughts on the future of psychedelics after attending the Horizons NYC psychedelics conference.⁠

View all media

Clinical Study of Psychedelic Drugs for Cancer Patients Could Be a ‘Game Changer’

The Huntsman Cancer Institute in Salt Lake City, Utah is investigating group psilocybin therapy as a treatment for anxiety and depression in cancer patients. Dr. Paul Thielking, who serves as the study’s lead therapist, explains that even just one dose of psilocybin could entirely shift the patient’s perspective on their illness and situation. Even more remarkable? The effects of those experiences seem to last—in some case, more than four years.

Can Microdosing Psychedelics Boost Mental Health? Here’s What the Evidence Suggests

Microdosing. Does it work? Amidst increased buzz around the benefits of the practice, research continues to tackle this difficult question. This week, a new double-blind study revealed that microdosing with LSD produces “negligible changes in mood and cognition”, and there has been no research on the efficacy for people suffering from anxiety and depression. Check out National Geographic’s microdosing feature to learn more about current research, perspectives, and remaining questions.

For further information, email us: 
[email protected]

We’re hiring!
Check out current opportunities to join our growing team.

Was this email forwarded to you?
Subscribe to our weekly newsletter

Tags: , , , ,
Posted in All Recent Posts, Novamind Inc. | Comments Off on The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

VIDEO: Candente Copper $DNT.ca Announces New Deposit of 2.2Billion Pounds of Copper and 1.2Million Ounces Gold

Posted by AGORACOM at 12:21 PM on Thursday, February 3rd, 2022
http://blog.agoracom.com/wp-content/uploads/2020/08/candente-copper-for-blog1.jpg

TSX listed Candente Copper owns Canariaco Norte, a large, economic copper deposit in Peru that continues to advance technically and economically toward a sale or production decision. A 2022 Preliminary Economic Assessment (“PEA”) is nearing completion that will advance it further toward development

Now it has a sister deposit, Canariaco Sur located 2km away that could help advance developments much quicker.

Canariaco Sur contains 2.2 billion pounds of copper and 1.2 million ounces of gold in an inferred resource calculated with only 15 holes, demonstrating a considerable amount of metal.
Sur contains higher levels of gold and molybdenum than Cañariaco Norte, minimal arsenic levels and mineralization that starts at surface. Cañariaco Sur has the potential to add significant value to the resources at Cañariaco Norte, 2km to the northeast.

Cañariaco Norte is a 100% owned pre-feasibility-stage porphyry copper deposit containing 7.5B pounds Measured and Indicated and can be mined for 22 years once in production. Oh, and Canariaco Norte is in the lowest quartile of production costs for projects waiting to be developed at around 0.98c per pound of copper. If that doesn’t have your attention, the third party validation will, look at these partners supporting Candente in 4 research papers comparing various global copper projects in the last 4 years as it now moves 2 deposits toward development:

RFC Ambrian: Cañariaco Norte in top 10 of 23 projects with potential to involve third party M&A (December 2021)
Haywood: Cañariaco Norte is one of 18 assets selected as likely to be considered by majors looking to acquire (December 2021)
Deutsche Bank: Cañariaco Norte identified as one of 3 projects required to meet the upcoming copper supply-demand gap (February 2021)
Goldman Sachs: Cañariaco Norte identified with incentive copper price in the lowest quartile of the top 84 copper projects worldwide (October 2018)

Canariaco Norte is a deposit itching to become a mine and Candente continues to advance the project forward with studies evaluating various methodologies to reduce CAPEX with multiple scenarios that support developing Canariaco closer to a production scenario.

With the price of copper firmly above $4 dollars, the economics supporting Canariaco going into production only gets stronger, and now Canariaco has a sister deposit helping to expedite matters.
Watch this great interview with Candente CEO Joanne Freeze as walks through Canariaco Sur and the exciting new developments aiding the development of 2 exciting copper porphyry deposits.

Tags: , , , , ,
Posted in All Recent Posts, Beyond The Press Release, Candente Copper | Comments Off on VIDEO: Candente Copper $DNT.ca Announces New Deposit of 2.2Billion Pounds of Copper and 1.2Million Ounces Gold

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 10:34 AM on Saturday, January 29th, 2022

The Roundup

A weekly summary of Novamind news and media

Novamind Announces Closing of CAD$5 Million Private Placement with Institutional Investor

We are pleased to announce the closing of our previously announced private placement to an institutional investor.

Read the full release here.

January 26, 2022

View all press releases

January 25, 2022

What Causes Depression and Can Psychedelics Help?

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore the topic of depression and whether or not psychedelic medicine can help treat it. They discuss the following: depression and suicidal ideation, ketamine treatment for depression, the qualities to look for in a professional helper, and much more.

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com. 

Email us questions and feedback at [email protected].

January 26, 2022

Remarkable Secrets of Ketamine

Chief Medical Officer, Dr. Reid Robison sits down with The Dales Report to discuss his involvement in a number of studies involving ketamine and other drugs that target the same mechanisms. Many of the questions he’s asked along the way focus on safety considerations and optimal conditions for treatment.

Watch the full interview here.

View all media

The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of

While classic psychedelics work towards FDA approval, global drug developers are moving beyond traditional plant medicines to focus their attention on the creation of novel “precision psychedelics”, compounds with shorter trips, less side effects, and, in some cases, no hallucinogenic component. Researchers are hopeful their efforts will increase access and scalability of psychedelic treatment. “I try to think of my mom,” one COMPASS chemist explains. “If she had to have this medication, what would I want for her as an ideal compound and ideal experience?” 

Overdose Deaths Hit a Historic High in 2020. Frustrated Experts Say These Strategies Could Save Lives

100,000 overdose deaths occurred in the U.S. between April 2020 and April 2021. Despite the steady rise of overdose deaths in the U.S. over the last two decades, the latest data raises an alarm about the increased need for substance use disorder prevention and treatment. Novamind recently announced plans to develop an innovative substance use disorder program. We’re also hosting a clinical trial for ketamine-assisted psychotherapy + mindfulness for opioid use disorder. Read about it here.

For further information, email us: 
[email protected]

We’re hiring!
Check out current opportunities to join our growing team.

Was this email forwarded to you?
Subscribe to our weekly newsletter

Tags: , , , , ,
Posted in All Recent Posts, Novamind Inc. | Comments Off on The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:28 AM on Saturday, January 22nd, 2022

The Roundup

A weekly summary of Novamind news and media

Novamind Closes Arizona Acquisition

We are pleased to announce that, further to our press release dated December 23, 2021, we have closed our acquisition of Arizona-based Foundations for Change, Inc., a mental health practice specialized in ketamine-assisted psychotherapy.

“We’re thrilled to welcome the team from Foundations,” commented Novamind CEO and Director, Yaron Conforti. “The Acquisition is an exciting opportunity for Novamind to expand the reach of our clinic network, bringing our model for innovative mental healthcare to a new market in Arizona.”

With the closing of the Acquisition, Foundations founder Jeff Edelman, MSN, APRN, PMHNP-BC, PMHCNS-BC, assumes the role of Medical Director at the Peoria and Phoenix clinic locations.

Mr. Edelman commented: “Joining Novamind is the right fit for our team and aligns with our mission to provide innovative and compassionate mental healthcare. I would like to thank our patients, partners and community for their ongoing support over the years. We look forward to integrating our team and operations with Novamind and benefiting from its deep expertise and infrastructure as we continue to serve a growing patient population.”

Read the full release here.

January 18, 2022

Novamind to Participate in Citi’s Psychedelic Drug Video Call Series

We are pleased to announce our participation in Citi’s Psychedelic Drug Video Call Series to be held virtually on January 25, 2022.

Neena Bitritto-Garg, Vice President Research Analyst, Biotech, at Citi, will host Novamind’s Chief Executive Officer, Yaron Conforti and Chief Medical Officer, Reid Robison, MD, MBA, for a fireside chat at 10:00 AM ET.

“Novamind has an established track record as a leader in commercializing psychedelic medicine and other innovative mental health therapies through a growing network of clinics and hosting an exciting pipeline of clinical trials for major drug developers,” said Mr. Conforti. “I look forward to introducing Citi’s clients to Novamind and expanding our relationships with a global base of institutional investors.”

To register for the call, please contact your Citi representative directly.
 

January 20, 2022

View all press releases

January 18, 2022

Can Psychedelics Change Your Personality?

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore whether or not psychedelic medicine can change your personality. They discuss the following: alter states for altered traits, “ego” and how psychedelic medicine can lead to personality changes, and much more.

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com. 

Email us questions and feedback at [email protected].

January 14, 2022

Psychedelic Therapies Continue to Be Seen as Big Trend in Mental Health Treatment

In the latest issue of Mental Health Weekly, Chief Medical Officer Dr. Reid Robison discusses the benefits and barriers of psychedelic treatment and weighs in on the progress of MDMA & psilocybin research and legislative activities in the US.

View all media

Two Thirds of Physicians Surveyed Believe Psilocybin Therapy Has Potential Benefit for Patients With Treatment-Resistant Depression

Perceptions on the potential of psilocybin therapy are shifting in the medical community, according to a recent COMPASS Pathways-sponsored survey. “Severe mental illnesses, such as treatment-resistant depression, have affected too many people in society for too long. Physicians are looking for new approaches to accelerate the healing process, particularly for patients for whom current therapies have failed.” 

MAPS Publishes Open Science Approach to Synthesizing MDMA

A new study by Jay Nair and colleagues from MAPS PBC tries to answer the question of how psychedelic substances will be produced. This is an important step and still, “Many open questions remain about the legal framework that needs to materialize, who will distribute the medicines, and who will be qualified to provide the treatment.” Dr. Robison sat down with Mental Health Weekly for similar conversation.

How Western Medicine Can Adapt to Psychedelic-Assisted Psychotherapy

Lucid News’ Itzhak Beery explores the role of shamanism in Western medicine. “Some psychotherapists feel pressured to offer this type of healing to their clients, who have heard about these magical treatments and hope for a short cut to relief. Most facilitators do not acknowledge the element of spirit or the unseen world.” We’ve also explored this question (and more) in a previous episode of the Psychedelic Frontiers Podcast. Listen to it again here.

For further information, email us: 
[email protected]

We’re hiring!
Check out current opportunities to join our growing team.

Was this email forwarded to you?
Subscribe to our weekly newsletter

Tags: , , , , , ,
Posted in All Recent Posts, Novamind Inc. | Comments Off on The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 11:04 AM on Saturday, January 8th, 2022

A weekly summary of Novamind news and media

*The above image is a rendering and may be subject to change.

Novamind Unveils New Design Concept for Clinics

We are pleased to unveil our clinic design concept to accommodate the unique requirements of psychedelic-assisted psychotherapy. The design concept will launch first in Novamind’s Park City, Utah location, and later across Novamind’s de novo clinics. Select design elements and principles will be integrated within existing clinic locations.

Inclusive and welcoming, the design concept enhances the patient experience at Novamind clinics, prioritizing patient safety and privacy, and utilizing evidence-based therapeutic elements to optimize patient care, including:

  • Biophilic designs that mimic nature and emphasize light interplay and neutral colour theory
  • Walking paths designed to minimize disruption and traffic across the clinic, creating a sense of privacy and tranquility
  • Curved treatment spaces, representing the protective space of cocoons, to facilitate the more sedentary experience of ketamine treatment
  • Larger treatment rooms to accommodate group therapy programs and support movement and more active patient behaviours associated with MDMA, psilocybin and other psychedelic medicines when approved by the FDA
  • To create the Design Concept, Novamind contracted DesignAgency, an internationally recognized interior design firm with clients that include the Four Seasons Hotels, MGM Resorts, Momofuku restaurants, Soho House and others. DesignAgency worked closely with Novamind’s clinical team to incorporate a host of therapeutic considerations into the design blueprint to achieve optimal patient experiences.

“We collaborated with Novamind’s clinical team and understood the importance of ‘set and setting’ in psychedelic medicine,” said Matt Davis, Co-Founder and Principal at DesignAgency. “The goal was to create spaces that allow patients to have a holistic experience and signal hope and healing well before they walk through the door.”

Dr. Reid Robison, Chief Medical Officer at Novamind, commented: “This new concept, combined with Novamind’s standard operating procedures, creates the most welcoming and effective healing environment possible. We wanted our clinics to be comforting, inviting and calming. With guidance from the DesignAgency team, we now have the blueprint to create spaces that elevate our patients’ healing experience.”

To see renderings of the Design Concept, click here.

January 5, 2022

View all press releases

January 4, 2022

“What is Integrative Medicine?” with Dr. Amy de la Garza

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Dr. Amy de la Garza. Amy is the Substance Use Disorder Program Director at Novamind and the Medical Director of the Salt Lake City clinic. Amy is a board-certified family practice physician who for the last 10 years has been providing specialized integrative healthcare for behavioral health, substance use, and a variety of other conditions.

December 29, 2021

Essential Qualities and Skills of the Psychedelic Therapist

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison discuss qualities and skills they think are essential for therapists who provide psychedelic-assisted psychotherapy.

We’re celebrating 8 months of the podcast with a GIVEAWAY on Instagram! Enter to win a sweatshirt featuring the audio waves from a fan-favorite episode of Psychedelic Therapy Frontiers.

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com. 

Email us questions and feedback at [email protected].

December 23, 2021

Novamind Expands To Arizona

Benzinga covers our expansion into Arizona highlighting the signed definitive agreement to acquire the Foundations for Change clinics. 

View all media

Health Canada’s Special Access Program Will Now Allow Doctors To Request Patient Access To Psychedelics

This is big news for Canada overall. “Long-awaited amendments to Health Canada’s Special Access Program have finally been made, potentially opening the door to less onerous access to the medical access of psychedelics like psilocybin and MDMA for patients in need.” Our mission has always been to increase access to these life-changing therapies and drugs in safe and regulated settings. We celebrate this news and will continue to do our part to bring psychedelic medicine to as many people in need as possible.   

Psychedelic Healthcare in 2021

PSYCH covers the year in psychedelic healthcare. “2021 was a seminal year for psychedelic medicine, with data released from groundbreaking clinical trials harnessing MDMA and psilocybin.” 2021 was special, but we can’t wait to work on making 2022 even more impactful for people around the world. For more great psychedelic content from PSYCH, download the third edition of the Psychedelics as Medicine Report here.

Ketamine Therapy Swiftly Reduces Depression and Suicidal Thoughts

Dr. Reid Robison and the team at Novamind have spent years providing ketamine-assisted psychotherapy and seeing the positive benefits firsthand. It’s changed the lives of thousands of our patients. We recently published a story about how ketamine helped a mother struggling with severe depression and a struggling marriage. You can read it here. Seeing the results of this systematic review by the University of Exeter is both exciting and validating. “Ketamine therapy has a swift short-term effect on reducing symptoms of depression and suicidal thoughts, according to a review of all the available evidence.”

For further information, email us: 
[email protected]

We’re hiring!
Check out current opportunities to join our growing team.

Was this email forwarded to you?
Subscribe to our weekly newsletter

Tags: , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Novamind Inc. | Comments Off on The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

« Older Entries
Newer Entries »